Literature DB >> 12167717

Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B.

Michael P Scheid1, Paola A Marignani, James R Woodgett.   

Abstract

The protein kinase B (PKB)/Akt family of serine kinases is rapidly activated following agonist-induced stimulation of phosphoinositide 3-kinase (PI3K). To probe the molecular events important for the activation process, we employed two distinct models of posttranslational inducible activation and membrane recruitment. PKB induction requires phosphorylation of two critical residues, threonine 308 in the activation loop and serine 473 near the carboxyl terminus. Membrane localization of PKB was found to be a primary determinant of serine 473 phosphorylation. PI3K activity was equally important for promoting phosphorylation of serine 473, but this was separable from membrane localization. PDK1 phosphorylation of threonine 308 was primarily dependent upon prior serine 473 phosphorylation and, to a lesser extent, localization to the plasma membrane. Mutation of serine 473 to alanine or aspartic acid modulated the degree of threonine 308 phosphorylation in both models, while a point mutation in the substrate-binding region of PDK1 (L155E) rendered PDK1 incapable of phosphorylating PKB. Together, these results suggest a mechanism in which 3' phosphoinositide lipid-dependent translocation of PKB to the plasma membrane promotes serine 473 phosphorylation, which is, in turn, necessary for PDK1-mediated phosphorylation of threonine 308 and, consequentially, full PKB activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167717      PMCID: PMC134003          DOI: 10.1128/MCB.22.17.6247-6260.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site.

Authors:  A Toker; A C Newton
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

2.  Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase.

Authors:  M M Hill; M Andjelkovic; D P Brazil; S Ferrari; D Fabbro; B A Hemmings
Journal:  J Biol Chem       Date:  2001-05-23       Impact factor: 5.157

Review 3.  Oncogenic kinase signalling.

Authors:  P Blume-Jensen; T Hunter
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

4.  Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1.

Authors:  R A Currie; K S Walker; A Gray; M Deak; A Casamayor; C P Downes; P Cohen; D R Alessi; J Lucocq
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

5.  The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells.

Authors:  M R Williams; J S Arthur; A Balendran; J van der Kaay; V Poli; P Cohen; D R Alessi
Journal:  Curr Biol       Date:  2000-04-20       Impact factor: 10.834

6.  Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation.

Authors:  N Filippa; C L Sable; B A Hemmings; E Van Obberghen
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.

Authors:  M Frödin; C J Jensen; K Merienne; S Gammeltoft
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

8.  Activation of protein kinase B/cAkt in hepatocytes is sufficient for the induction of expression of the gene encoding glucokinase.

Authors:  P B Iynedjian; R A Roth; M Fleischmann; A Gjinovci
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

9.  Oncogenic transformation of cells by a conditionally active form of the protein kinase Akt/PKB.

Authors:  A M Mirza; A D Kohn; R A Roth; M McMahon
Journal:  Cell Growth Differ       Date:  2000-06

Review 10.  The PI3K-PDK1 connection: more than just a road to PKB.

Authors:  B Vanhaesebroeck; D R Alessi
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

View more
  115 in total

1.  Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice.

Authors:  Zhong Q Wang; Xian H Zhang; Yongmei Yu; Alexander Poulev; David Ribnicky; Z Elizabeth Floyd; William T Cefalu
Journal:  J Nutr Biochem       Date:  2011-01-28       Impact factor: 6.048

2.  Coordinate control of host centrosome position, organelle distribution, and migratory response by Toxoplasma gondii via host mTORC2.

Authors:  Yubao Wang; Louis M Weiss; Amos Orlofsky
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

3.  Plasma membrane recruitment and activation of the AGC kinase Ypk1 is mediated by target of rapamycin complex 2 (TORC2) and its effector proteins Slm1 and Slm2.

Authors:  Brad J Niles; Huzefa Mogri; Andrew Hill; Ariadne Vlahakis; Ted Powers
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 4.  Influence of arsenate and arsenite on signal transduction pathways: an update.

Authors:  Ingrid L Druwe; Richard R Vaillancourt
Journal:  Arch Toxicol       Date:  2010-05-26       Impact factor: 5.153

5.  Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation.

Authors:  Michael P Scheid; Michael Parsons; James R Woodgett
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

Review 6.  Alterations and molecular targeting of the GSK-3 regulator, PI3K, in head and neck cancer.

Authors:  Michelle J Lee; Nan Jin; Jennifer R Grandis; Daniel E Johnson
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-02-19       Impact factor: 4.739

7.  Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival.

Authors:  Jeffrey C Rathmell; Casey J Fox; David R Plas; Peter S Hammerman; Ryan M Cinalli; Craig B Thompson
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer.

Authors:  Jennifer R Bean; Sarah R Hosford; Lynn K Symonds; Philip Owens; Lloye M Dillon; Wei Yang; Kevin Shee; Gary N Schwartz; Jonathan D Marotti; Kristen E Muller; Kari M Rosenkranz; Richard J Barth; Vivian S Chen; Veena R Agarwal; Todd W Miller
Journal:  Breast Cancer Res Treat       Date:  2014-12-10       Impact factor: 4.872

9.  Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis.

Authors:  Ivelisse Gonzalez; Gyanendra Tripathi; Emma J Carter; Laura J Cobb; Dervis A M Salih; Fiona A Lovett; Cathy Holding; Jennifer M Pell
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells.

Authors:  Ruiting Lin; Siyuan Xia; Changliang Shan; Dong Chen; Yijie Liu; Xue Gao; Mei Wang; Hee-Bum Kang; Yaozhu Pan; Shuangping Liu; Young Rock Chung; Omar Abdel-Wahab; Taha Merghoub; Michael Rossi; Ragini R Kudchadkar; David H Lawson; Fadlo R Khuri; Sagar Lonial; Jing Chen
Journal:  Mol Cell       Date:  2018-03-15       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.